CHAPTER 1 INTRODUCTION

1.1. REPORT DESCRIPTION
1.2. KEY BENEFITS FOR STAKEHOLDERS
1.3. KEY MARKET SEGMENTS
1.4. RESEARCH METHODOLOGY

1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models

CHAPTER 2 EXECUTIVE SUMMARY

2.1. KEY FINDINGS OF THE STUDY
2.2. CXO PERSPECTIVE

CHAPTER 3 MARKET OVERVIEW

3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS

3.2.1. Top investment pockets
3.2.2. Market share analysis, 2016

3.3. MARKET DYNAMICS

3.3.1. Drivers

3.3.1.1. Rise in number of patients suffering from chronic diseases
3.3.1.2. Increasing pool of geriatric population
3.3.1.3. Technological advancements
3.3.1.4. Increasing government focus on funding R&D initiatives

3.3.2. Restraints

3.3.2.1. High cost of treatment
3.3.2.2. Stringent approval process

3.3.3. Opportunities

3.3.3.1. Lucrative opportunities in emerging economies

3.3.4. Impact Analysis

3.4. GOVERNMENT REGULATIONS
3.5. CLINICAL TRIALS

CHAPTER 4 GLOBAL MEDICAL BIONICS MARKET, BY PRODUCT

4.1. OVERVIEW

4.1.1. Market size and forecast

4.2. VISION BIONICS/ BIONICS EYE

4.2.1. Key market trends
4.2.2. Growth factors and opportunities
4.2.3. Market size and forecast

4.3. EAR BIONICS

4.3.1. Key market trends
4.3.2. Growth factors and opportunities
4.3.3. Market size and forecast

4.3.3.1. Cochlear implants
4.3.3.2. Market size and forecast
4.3.3.3. Bone Anchored Hearing Systems (BAHS)
4.3.3.4. Market size and forecast
4.3.3.5. Auditory brainstem implants
4.3.3.6. Market size and forecast

4.4. ORTHOPEDIC BIONICS

4.4.1. Key market trends
4.4.2. Growth factors and opportunities
4.4.3. Market size and forecast

4.4.3.1. Upper limb
4.4.3.2. Market size and forecast
4.4.3.3. Lower limb
4.4.3.4. Market size and forecast

4.4.3.4.1. Bionic knee
4.4.3.4.2. Market size and forecast
4.4.3.4.3. Bionic feet
4.4.3.4.4. Market size and forecast

4.4.3.5. Exoskeleton
4.4.3.6. Market size and forecast
4.4.3.7. Electrical bone growth stimulators
4.4.3.8. Market size and forecast

4.4.3.8.1. Invasive bone growth stimulators
4.4.3.8.2. Market size and forecast
4.4.3.8.3. Non-invasive bone growth stimulators
4.4.3.8.4. Market size and forecast

4.5. CARDIAC BIONICS

4.5.1. Key market trends
4.5.2. Growth factors and opportunities
4.5.3. Market size and forecast
4.5.4. Pacemaker

4.5.4.1. Implantable pacemaker
4.5.4.2. External pacemaker

4.5.5. Market size and forecast
4.5.6. Total artificial heart
4.5.7. Market size and forecast
4.5.8. Ventricular assist device (VADs)
4.5.9. Market size and forecast

4.5.9.1. Left Ventricular Assist Device (LVAD)
4.5.9.2. Market size and forecast
4.5.9.3. Right Ventricular Assist Device (RVAD)
4.5.9.4. Market size and forecast
4.5.9.5. Biventricular Assist Device (BIVAD)
4.5.9.6. Market size and forecast

4.5.10. Artificial Heart Valves
4.5.11. Market size and forecast

4.5.11.1. Mechanical Heart Valves
4.5.11.2. Market size and forecast
4.5.11.3. Tissue Heart Valves
4.5.11.4. Market size and forecast

4.6. NEURAL/BRAIN BIONICS

4.6.1. Key market trends
4.6.2. Growth factors and opportunities
4.6.3. Market size and forecast
4.6.4. Internal Neurostimulators
4.6.5. Market size and forecast

4.6.5.1. Deep Brain Stimulators (DBS)
4.6.5.2. Market size and forecast
4.6.5.3. Sacral Nerve Stimulators (SNS)
4.6.5.4. Market size and forecast
4.6.5.5. Vagus Nerve Stimulators (VNS)
4.6.5.6. Market size and forecast
4.6.5.7. Spinal Cord Stimulators (SCS)
4.6.5.8. Market size and forecast
4.6.5.9. Other Neurostimulators
4.6.5.10. Market size and forecast

4.6.6. External Neurostimulators (Transcutaneous Electrical Nerve Stimulation (TENS))
4.6.7. Market size and forecast

CHAPTER 5 GLOBAL MEDICAL BIONICS MARKET, BY METHOD OF FIXATION

5.1. OVERVIEW

5.1.1. Market size and forecast

5.2. IMPLANTABLE BIONICS

5.2.1. Market size and forecast

5.3. EXTERNAL BIONICS

5.3.1. Market size and forecast

CHAPTER 6 GLOBAL MEDICAL BIONICS MARKET, BY REGION

6.1. OVERVIEW
6.2. NORTH AMERICA

6.2.1. Key market trends
6.2.2. Key growth factors and opportunities
6.2.3. Market size and forecast
6.2.4. U.S. market size and forecast
6.2.5. Canada market size and forecast
6.2.6. Mexico market size and forecast

6.3. EUROPE

6.3.1. Key market trends
6.3.2. Key growth factors and opportunities
6.3.3. Market size and forecast
6.3.4. Germany market size and forecast
6.3.5. France market size and forecast
6.3.6. UK market size and forecast
6.3.7. Italy market size and forecast
6.3.8. Spain market size and forecast
6.3.9. Rest of Europe market size and forecast

6.4. ASIA-PACIFIC

6.4.1. Key market trends
6.4.2. Key growth factors and opportunities
6.4.3. Market size and forecast
6.4.4. Japan market size and forecast
6.4.5. China market size and forecast
6.4.6. India market size and forecast
6.4.7. Australia market size and forecast
6.4.8. Malaysia market size and forecast
6.4.9. Rest of Asia-Pacific market size and forecast

6.5. LAMEA

6.5.1. Key market trends
6.5.2. Key growth factors and opportunities
6.5.3. Market size and forecast
6.5.4. Brazil market size and forecast
6.5.5. South Africa market size and forecast
6.5.6. Saudi Arabia market size and forecast
6.5.7. Rest of LAMEA market size and forecast

CHAPTER 7 COMPANY PROFILES

7.1. ABOTT LABORATORIES

7.1.1. Company overview
7.1.2. Company snapshot
7.1.3. Operating business segments
7.1.4. Business performance
7.1.5. Key strategic moves and developments
7.1.6. Strategy share (%)

7.2. BOSTON SCIENTIFIC CORPORATION

7.2.1. Company overview
7.2.2. Company snapshot
7.2.3. Operating business segments
7.2.4. Business performance
7.2.5. Key strategic moves and developments
7.2.6. Strategy share (%)

7.3. COCHLEAR LTD.

7.3.1. Company overview
7.3.2. Company snapshot
7.3.3. Operating business segments
7.3.4. Business performance
7.3.5. Key strategic moves and developments
7.3.6. Strategy share (%)

7.4. LIVANOVA PLC

7.4.1. Company overview
7.4.2. Company snapshot
7.4.3. Operating business segments
7.4.4. Business performance
7.4.5. Key strategic moves and developments
7.4.6. Strategy share (%)

7.5. MEDTRONIC PLC

7.5.1. Company overview
7.5.2. Company snapshot
7.5.3. Operating business segments
7.5.4. Business performance
7.5.5. Key strategic moves and developments
7.5.6. Strategy share (%)

7.6. ORTHOFIX HOLDINGS, INC.

7.6.1. Company overview
7.6.2. Company snapshot
7.6.3. Operating business segments
7.6.4. Business performance
7.6.5. Key strategic moves and developments
7.6.6. Strategy share (%)

7.7. OSSUR

7.7.1. Company overview
7.7.2. Company snapshot
7.7.3. Operating business segments
7.7.4. Business performance
7.7.5. Key strategic moves and developments
7.7.6. Strategy share (%)

7.8. RETINA IMPLANT AG

7.8.1. Company overview
7.8.2. Company snapshot
7.8.3. Operating business segments
7.8.4. Business performance
7.8.5. Key strategic moves and developments
7.8.6. Strategy share (%)

7.9. SONOVA

7.9.1. Company overview
7.9.2. Company snapshot
7.9.3. Operating business segments
7.9.4. Business performance
7.9.5. Key strategic moves and developments
7.9.6. Strategy share (%)

7.10. SECOND SIGHT MEDICAL PRODUCTS, INC.

7.10.1. Company overview
7.10.2. Company snapshot
7.10.3. Operating business segments
7.10.4. Business performance
7.10.5. Key strategic moves and developments
7.10.6. Strategy share (%)

7.11. SYNCARDIA SYSTEMS, LLC

7.11.1. Company overview
7.11.2. Company snapshot
7.11.3. Operating business segments
7.11.4. Business performance
7.11.5. Key strategic moves and developments
7.11.6. Strategy share (%)

7.12. WILLIAM DEMANT HOLDING A/S

7.12.1. Company overview
7.12.2. Company snapshot
7.12.3. Operating business segments
7.12.4. Business performance
7.12.5. Key strategic moves and developments
7.12.6. Strategy share (%)